Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate.

J Lipid Res · 2023 · PMC10017426 · PMID 36737040

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantP = 0.053so close (0.05 < p ≤ 0.1)

Interestingly, the change in LDL-apoB FRR and plasma apoB concentration from baseline to week 12 of ACCi treatment displayed a borderline significant association ( P = 0.053) and negative correlation (r = −0.42).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.